|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from operating activities: | |
| Net income | |
| Adjustments to reconcile net income to net cash provided by operating activities: | |
| Depreciation and amortization | |
| Other assets impairment | |
| (Recovery) / impairment of investments in subsidiaries, associates and joint ventures | |
| Impairment of goodwill | |
| Equity method | |
| Credit impairment charges on loans and advances and financial leases | |
| Credit impairment charges on off balance sheet credit and other financial instruments | |
| Gain on sales of assets | |
| Valuation gain on investment securities | |
| Gain upon disposal of investment in subsidiaries, associates, and joint ventures | |
| Valuation on derivative financial instruments | |
| Income tax | |
| Bonuses and short-term benefits | |
| Dividends | |
| Investment property valuation | |
| Effect of exchange rate changes | |
| Other non-cash items | |
| Net interest | |
| Change in operating assets and liabilities: | |
| Decrease / (increase) in derivative financial instruments | |
| Decrease / (increase) in accounts receivable | |
| Increase in loans and advances to customers | |
| (Increase) / decrease in other assets | |
| Increase / (decrease) in accounts payable | |
| Increase / (decrease) in other liabilities | |
| Increase in deposits by customers | |
| Increase / (decrease) in estimated liabilities and provisions | |
| Net changes in investment securities recognized at fair value through profit or loss | |
| Proceeds from sales of assets held for sale and inventories | |
| Recovery of charged-off loans | |
| Income tax paid | |
| Dividend received | |
| Interest received | |
| Interest paid | |
| Net cash provided by operating activities | |
| Cash flows from investment activities: | |
| Purchases of debt instruments at amortized cost | |
| Proceeds from maturities of debt instruments at amortized cost | |
| Purchases of debt instruments at fair value through OCI | |
| Proceeds from debt instruments at fair value through OCI | |
| Purchases of equity instruments at fair value through OCI and interests in associates and joint ventures | |
| Proceeds from equity instruments at fair value through OCI and interests in associates and joint ventures | |
| Purchases of premises and equipment and investment properties | |
| Proceeds from sales of premises and equipment and investment properties | |
| Purchase of other long-term assets | |
| Net cash used in investing activities | |
| Cash flows from financing activities: | |
| Increase in repurchase agreements and other similar secured borrowing | |
| Proceeds from borrowings from other financial institutions | |
| Repayment of borrowings from other financial institutions | |
| Payment of lease liability | |
| Placement of debt instruments in issue | |
| Payment of debt instruments in issue | |
| Dividends paid | |
| Buyback of shares | |
| Transactions with non-controlling interests | |
| Net cash (used) provided in financing activities(4) | |
| Effect of exchange rate changes on cash and cash equivalents | |
| Increase / (decrease) in cash and cash equivalents | |
| Cash and cash equivalents at beginning of year | |
| Cash and cash equivalents at end of year |
Loading...
